Glaukos (GKOS) Net Income towards Common Stockholders Growth (1y) (2015 - 2026)
Glaukos (GKOS) Net Income towards Common Stockholders Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | -18.72% |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 13.91% |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -11.74% |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 98.96% |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | -30.10% |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 122.60% |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 89.28% |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | - |
| 10 | Glaukos | 7.36 Bn | 7.25 Bn | 117.23 Mn | -9.18% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.18% |
| Dec 31, 2025 | -43.90% |
| Sep 30, 2025 | 24.19% |
| Jun 30, 2025 | 61.11% |
| Mar 31, 2025 | 55.63% |
| Dec 31, 2024 | 12.58% |
| Sep 30, 2024 | 29.68% |
| Jun 30, 2024 | -54.21% |
| Mar 31, 2024 | -17.94% |
| Dec 31, 2023 | 45.02% |
| Sep 30, 2023 | -10.59% |
| Jun 30, 2023 | 28.02% |
| Mar 31, 2023 | -740.87% |
| Dec 31, 2022 | 391.37% |
| Sep 30, 2022 | -541.88% |
| Jun 30, 2022 | -160.47% |
| Mar 31, 2022 | 132.81% |
| Dec 31, 2021 | -125.16% |
| Sep 30, 2021 | 139.56% |
| Jun 30, 2021 | 56.18% |